What We Do
We are constructing a broad-based product portfolio of licensed, small-molecule chemotherapies, large protein immune-modulators and co-developed antibody biosimilars, Boston Oncology is a catalyst functioning at the intersection of medicine, research & technology, business and government.
Partnering for Progress
We harness the output of our global partners, leading scientific and medical producers, and the commercial infrastructure of our local partners to deliver best-in-class biopharmaceutical drugs to our target markets.
- Investors / Media